EXOZYMES INC. — Director's Dealing 2024

Nov 19, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08

Reporting Person: Opgenorth Paul Hideo (Vice President, Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	638160	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
SAFE for Common Stock	$6.40	2024-11-30	Common Stock (2344)		Direct
Stock Options for Common Stock	$2.44	2028-01-31	Common Stock (38955)		Direct
Restricted Stock Units for Common Stock	$2.44	2032-03-25	Common Stock (52720)		Direct
Restricted Stock Units for Common Stock	$3.32	2033-04-28	Common Stock (21893)		Direct

Footnotes

F1: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities.

F2: The shares underlying the grant vest at the rate of 649 shares each month and are fully vested on 01/31/2026.

F3: All shares are fully vested once issued.